Bright Minds Biosciences Updates Planned BMB-101 Study
Bright Minds Biosciences provided an update about a planned study of BMB-101 in developmental and epileptic encephalopathies.
Related stories
US Stocks Rise as Dow Gains 1.04%
The Dow rose 1.04%, the S&P 500 gained 0.58% and the Nasdaq advanced 0.72%.
M impact | EQUITY | Nov 02, 2026, 03:37 PM UTC
Wall Street Rises as Oil Falls Ahead of Midterm Elections
U.S. stocks rose as oil fell, with U.S. midterm elections and further earnings ahead.
M impact | EQUITY | Nov 02, 2026, 03:36 PM UTC
Bomb threat forces Wizz Air plane to make emergency landing
M impact | EQUITY | Nov 02, 2026, 03:36 PM UTC
Saccheria Franceschetti Makes Binding Offer to Acquire Saccheria Guala
M impact | EQUITY | Nov 02, 2026, 03:35 PM UTC
Cyberattack Causes Major Losses at Supermarkets in Seven European Countries
A cyberattack caused losses at dozens of supermarkets across at least seven European countries. The headline says the attack drove temperatures higher.
M impact | EQUITY | Nov 02, 2026, 03:35 PM UTC
ChatGPT Flaw Exposed Private Conversations Through Shared Links
A ChatGPT flaw allowed access to private conversations through a simple shared link.
M impact | EQUITY | Nov 02, 2026, 03:35 PM UTC